Response to the National Service Framework on coronary heart disease: is it sufficiently evidence-based?
Hobbs
F D
FD
Department of Primary Care and General Practice, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D003327:Coronary Disease / Q000517:prevention & control / Q000628:therapy; D003695:Delivery of Health Care / Q000592:standards; D019317:Evidence-Based Medicine; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006113:United Kingdom
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors